Search
Acute Ischemic Stroke Clinical Trials
A listing of 17 Acute Ischemic Stroke clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 17
There are currently 17 active clinical trials seeking participants for Acute Ischemic Stroke research studies. The states with the highest number of trials for Acute Ischemic Stroke participants are California, Shandong, Beijing and Henan.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Chronic Cough Clinical Study
Recruiting
We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Conditions:
Cough
Chronic Cough
Asthma
Allergic Asthma
Sinusitis
Featured Trial
Transcranial Magnetic Stimulation (TMS) for Obsessive Compulsive Disorder (OCD)
Recruiting
Transcranial magnetic stimulation (TMS) is an FDA-approved, non-invasive form of brain stimulation for OCD. TMS has been shown to be an effective form of treatment in individuals with OCD. By using a form of TMS termed theta-burst stimulation (TBS), we hope that this will result in a more effective treatment by producing faster symptom reduction. We are trialing a novel form of accelerated TMS, where we will deliver ten 10-minute sessions per day, for 5 days. This study will compare the efficacy of TMS for OCD at two distinct brain regions. Participants will be randomized into one of two study groups, and receive stimulation at either the DMPFC or R-OFC. Both regions have been linked to OCD by research. Patients that don't respond to their study region will have the option to receive stimulation at the other region.
Conditions:
Obsessive-Compulsive Disorder
Obsessive Compulsive Disorder
Obsessive Compulsive Disorder (OCD)
Obsessive-Compulsive Disorder (OCD)
Obsessive-compulsive Disorders and Symptoms
Featured Trial
High Triglyceride Clinical Research Study
Recruiting
Living with high triglycerides? See if our clinical study is right for you.
Don’t let financial stress hold you back. All clinical study-related assessments, care, and the investigational study drug are available at no cost. You could also be eligible for compensation for travel.
Don’t let financial stress hold you back. All clinical study-related assessments, care, and the investigational study drug are available at no cost. You could also be eligible for compensation for travel.
Conditions:
High Triglycerides
High Triglyceride Level
Hypertriglyceridemia
Elevated Triglycerides
Triglycerides High
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
Recruiting
The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/13/2025
Locations: Banner University of Arizona Medical Center, Tucson, Arizona +165 locations
Conditions: Acute Ischemic Stroke
Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic Strokes
Recruiting
Study using ultrasound of the brain as a diagnostic tool to differentiate between ischemic stroke and hemorrhagic stroke. Correlation of brain perfusion and size of stroke in relation to systemic hemodynamic targets will be assessed on serial scans.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/02/2025
Locations: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Conditions: Acute Ischemic Stroke, Hemorrhagic Stroke
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Recruiting
The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circulation and have a proximal carotid occlusive disease (occlusion or severe stenosis).
Gender:
ALL
Ages:
Between 18 years and 79 years
Trial Updated:
12/02/2024
Locations: Mobile Infirmary Medical Center, Mobile, Alabama +33 locations
Conditions: Acute Ischemic Stroke
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Recruiting
The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
11/15/2024
Locations: Yale University Hospital, New Haven, Connecticut +25 locations
Conditions: Acute Ischemic Stroke
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Recruiting
The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset.
Participants will be randomized to receive one dose of either the investigational drug or placebo and will be followed for 90 days. A total of 156 patients are planned in this study.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/29/2024
Locations: Mills Peninsula Medical Center, Burlingame, California +6 locations
Conditions: Acute Ischemic Stroke
REal-World Analyses of Stroke - Thrombus Occlusion REtrieval
Recruiting
To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of MicroVention market-released acute ischemic stroke devices when used at the direction of the treating physician.
Gender:
ALL
Ages:
All
Trial Updated:
09/09/2024
Locations: Pacific Neuroscience Institute (Providence), Burbank, California +36 locations
Conditions: Acute Ischemic Stroke, Stroke, Ischemic, Vessel Occlusion
Safety Study of PP-007 in Subjects With Acute Ischemic Stroke
Recruiting
The HEMERA-1 Extension (Part III) is a prospective, open-label, multicenter study to evaluate safety of two doses of PP-007 in Acute Ischemic Stroke (AIS) subjects receiving Intravenous Thrombolysis (IVT) or mechanical thrombectomy (MT) or IVT+MT as standard of care (SOC). Subjects will receive two doses of PP-007 infusion 24 ± 6 hours apart in addition to the site-specific SOC protocol. PP-007 is PEGylated bovine carboxyhemoglobin and will be administered via IV infusion. The effects on collate... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/28/2024
Locations: Baptist Health Research Institute, Jacksonville, Florida +7 locations
Conditions: Acute Ischemic Stroke
Blood Pressure Variability and Ischemic Stroke Outcome
Recruiting
The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are:
1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke.
2. To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome.
3. To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/19/2024
Locations: Yale-New Haven Hospital, New Haven, Connecticut +2 locations
Conditions: Acute Ischemic Stroke, Blood Pressure Variability
Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI
Recruiting
The goal is to pilot test a highly accessible, web-based, pragmatic, scalable intervention to overcome ongoing problems with high stakes decision-making by surrogate decision-makers of patients in ICUs with severe acute brain injury (SABI), including those with moderate-severe traumatic brain injury, large hemispheric acute ischemic stroke and intracerebral hemorrhage.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/09/2024
Locations: Johns Hopkins Bayview Medical Center, Baltimore, Maryland +2 locations
Conditions: Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury
Brain, Blood And Clot or Tissue Registry And Collaboration
Recruiting
This is a prospective open enrollment biorepository to collect and evaluate blood and tissue collected during cerebrovascular procedures, which will then be used for the purposes of identifying biological markers, inflammatory cell infiltrates, and biological states in stroke and other cerebrovascular diseases in the human condition.
The study population will include up to 1000 subjects with cerebrovascular disease or suspected cerebrovascular disease. Male and female participants 18 years of a... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/07/2024
Locations: University of Kentucky Deparment of Neurosurgery, UK Chandler Hospital, Lexington, Kentucky
Conditions: Acute Ischemic Stroke, Cerebrovascular Disorders
Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct
Recruiting
This is a randomized open-label, with blinded outcome pilot study to evaluate the effect on inflammatory laboratory values and explore clinical outcomes in patients who present with ischemic strokes due to large vessel occlusions and are treated with either current accepted management, or accepted management in addition to transcutaneous auricular vagal nerve stimulation.
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
12/05/2023
Locations: Washington University in St. Louis School of Medicine, Saint Louis, Missouri
Conditions: Acute Ischemic Stroke
Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
Recruiting
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/19/2023
Locations: Touro Infirmary New Orleans, New Orleans, Louisiana
Conditions: Acute Ischemic Stroke
1 - 12 of 17